Ultima-AOD 9604 2mg

Manufacturer: Ultima Pharmaceuticals

Pharmaceutical name: Anti-Obesity Drug-9604

Pack: 1 vial (2 mg)

AOD 9604 is a modified variant of Growth Hormone, which consists of 191 amino acids. The last 15 amino acids (176-191) of the Growth Hormone sequence have been synthesized into a specific peptide known as GH Frag 176-191 or AOD 9604.

 

AOD 9604 is considered one of the most effective peptides for weight loss. It also offers additional advantages that may aid in fat reduction, improved metabolism, and more.

 

Gland Stimulated: Pituitary Gland

 

Benefits of AOD 9604:

 

Decreases Body Fat

Stimulates the release of fat from obese adipocytes rather than lean ones

Replicates the way natural growth hormone governs fat metabolism

No negative effects on blood sugar levels or growth

AOD-9604 promotes lipolysis

Prevents lipogenesis, the conversion of non-fat foods into body fat

AOD 9604 has demonstrated very positive effects on cartilage repair and regenerative capabilities, especially when used alongside peptide BPC 157.

 

Mechanism of Action:

 

AOD-9604, alternatively known as Tyr-hGH Frag 176-191, has been shown to possess a significant fat-burning effect without inducing a craving to overeat. It does not influence blood sugar or tissue development. (Heffernan 2001, Ng 2000). AOD-9604 facilitates fat degradation and burning (oxidation) through a mechanism that does not involve hGH receptors. It operates independently of hGH. Laboratory research on rodents, pigs, dogs, and humans has elucidated that AOD-9604 encourages fat release primarily from obese fat cells while simultaneously minimizing the formation of new fat in those cells and enhancing fat oxidation. Remarkably, AOD-9604 excels at diminishing abdominal fat stores.

 

The second most potent peptide for fat loss is CJC-1295, as it promotes an increase in overall GH levels in the body (contrary to what typically occurs as people age), which explains why individuals tend to accumulate fat as they grow older. If your primary objective is fat loss, it's generally advisable to avoid products like GHRP (GHRP-6, GHRP-2, or GHRH precursors) since they may lead to increased hunger and elevated cortisol levels. AOD-9604 does not stimulate appetite or raise cortisol levels.

AOD 9604 Research:

 

AOD-9604 (Advanced Obesity Drug) was initially developed by Professor Frank Ng at Monash University in Australia during the 1990s, aiming to create an anti-obesity medication that yields the fat-burning effects of human growth hormone (HGH) without promoting muscle growth.

 

Recent studies have indicated that, in addition to its fat loss capabilities, AOD 9604 possesses numerous regenerative properties linked to growth hormone. Presently, clinical trials are being conducted to explore the use of AOD 9604 in treatments for osteoarthritis, hypercholesterolemia, and in the repair of bone and cartilage.

 

Results from oral glucose tolerance tests revealed that, unlike hGH, AOD 9604 does not adversely affect carbohydrate metabolism. No anti-AOD 9604 antibodies were detected in any subjects screened for antibody response. Throughout all studies, there were no withdrawals or serious adverse events linked to AOD 9604 usage.